arrow
H

Hiroyuki Yamaguchi

Nagasaki University
H指数:33
被引数:4,227

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

THE EFFICACY AND SAFETY OF AVACOPAN IN REMISSION INDUCTION THERAPY FOR MPA/GPA AND THE EFFECTS OF AVACOPAN ON SERUM C5a AND S100A9 LEVELS: A SINGLE-CENTER STUDY IN JAPAN

AVACOPAN在MPA/GPA缓解诱导治疗中的有效性与安全性及AVACOPAN对血清C5a和S100A9水平的影响:一项日本单中心研究

2024-06-010
PRE
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)
2023-12-011
OA
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer

预后营养指数和肺免疫预后指数作为免疫检查点抑制剂联合细胞毒抗癌化疗治疗晚期非小细胞肺癌患者的预后预测指标

2022-02-0629
OAAI
Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
2021-09-174
OAAI
Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study
2021-07-0835
OAAI
Impact of Corticosteroid Administration within 7 Days of the Hospitalization for Influenza Pneumonia with Respiratory Failure: A Propensity Score Analysis Using a Nationwide Administrative Database
2021-01-319
OAAI
Novel and potent antimicrobial effects of caspofungin on drug-resistant Candida and bacteria
2020-10-2020
OAAI
A phase II study of Osimertinib for patients with radiotherapy-naive CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)
2020-05-019
OAAI